Cocrystal Pharma, Inc.COCPNASDAQ

Revenue (LTM)

Net Income (LTM)

$-18M

+2.7% YoY

Free Cash Flow

$-16M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	2	0	0	0	0
Gross Profit	-4	-9↓118.8%	-12↓40.9%	-15↓22.4%	-13↑17.4%
Operating Income	-10	-14↓48.4%	-39↓173.0%	-19↑52.2%	-18↑3.7%
Net Income	-10	-14↓47.0%	-39↓173.8%	-18↑53.7%	-18↑2.7%
EBITDA	-9	-14↓48.8%	-18↓27.9%	-21↓16.8%	-18↑15.3%
EPS Diluted	-2.01	-1.85↑8.0%	-4.77↓157.8%	-0.00↑100.0%	-1.72↓90426.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	33	59↑77.8%	37↓36.7%	26↓29.1%	10↓62.6%
Total Current Assets	34	59↑74.4%	40↓32.3%	29↓27.6%	12↓60.2%
Total Assets	54	79↑46.4%	41↓48.6%	31↓23.5%	13↓57.0%
Total Current Liabilities	1	2↑13.8%	1↓21.3%	3↑168.3%	2↓25.6%
Total Liabilities	2	2↑6.1%	1↓30.9%	5↑283.0%	4↓19.3%
Total Equity	53	78↑47.7%	40↓49.0%	26↓33.3%	10↓63.9%
Total Debt	1	1↓10.4%	0↓44.4%	2↑523.9%	2↓2.5%
Net Debt	-32	-58↓79.5%	-37↑36.7%	-25↑33.5%	-8↑67.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-10	-13↓29.4%	-21↓68.5%	-15↑31.6%	-16↓12.4%
Capital Expenditure	-0	-0↑78.3%	-0↓42.3%	-0↓59.5%	-0↑93.2%
Free Cash Flow	-10	-13↓26.8%	-22↓68.4%	-15↑31.3%	-16↓11.6%
Stock-Based Comp	1	1↑9.4%	1↑18.1%	1↓6.3%	1↓19.7%
Net Change in Cash	26	26↑0.4%	-22↓183.8%	-11↑49.9%	-16↓52.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance